Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study
about
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia.Mirogabalin and emerging therapies for diabetic neuropathy
P2860
Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@ast
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@en
type
label
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@ast
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@en
prefLabel
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@ast
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@en
P2093
P2860
P356
P1476
Efficacy and safety of 40 mg o ...... zed, 52-week, open-label study
@en
P2093
Atsunori Kashiwagi
Hitoshi Yasuda
Levent Alev
Masato Kasuga
Nigishi Hotta
Ryuzo Kawamori
Tadaaki Yamada
P2860
P304
P356
10.1111/JDI.12361
P577
2015-05-18T00:00:00Z